PTC Therapeutics Inc Corporate Call - PTC299 for the Potential Treatment of COVID-19 Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the conference call to discuss PTC299 for the potential treatment of COVID-19. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Alex Kane, Executive Director of Investor Relations. Thank you. Please go ahead, sir.
Thank you, and good morning to everyone joining us. Welcome to the PTC Therapeutics conference call to discuss PTC299 for the potential treatment of COVID-19. Joining me on today's call is our Chief Executive Officer, Stuart Peltz. In conjunction with today's call and webcast, we have posted slides that will be referenced throughout the call, which can be found on the Events & Presentations page under the Investor Relations section of PTC Therapeutics website at www.ptcbio.com.
Before we start, let me remind you that today's call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |